Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Malignant T-cell-amplified sequence 1' and Ligand = 'BDBM345278'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345278 (2-[[1-[(2-Chlorophenyl)methyl]-5-(3- thienyl)pyra...) Show SMILES CC(C)(OCc1cc(-c2ccsc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C19H19ClN2O3S/c1-19(2,18(23)24)25-11-15-9-17(14-7-8-26-12-14)22(21-15)10-13-5-3-4-6-16(13)20/h3-9,12H,10-11H2,1-2H3,(H,23,24)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair